HopeStage
Back to all studies
RecruitingNCT06732596

Smartphone conversational support during buprenorphine treatment

About this titleRead the official source — NCT06732596
Interventional studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

Participants are randomly assigned to a smartphone conversational-agent support programme or usual care. The app group receives technical help, reminders and incentives to use the animated agent. Assessments take place in person at baseline and by phone at six and 12 months, with brief contact checks at months three and nine.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 30, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
Boston Medical Center
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
Other
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06732596
Official title
Show the full official title

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

Recruitment & locations

Currently recruiting

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston Medical Center, a hospital or academic medical center.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies